Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States

Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. Patients outside clinical trials seldom benefit from evidence‐based monitoring. The objective of this study was to estimate the cost‐effectiveness of complying with HCC screening guidelines. The economic evaluat...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Hepatology (Baltimore, Md.) Ročník 65; číslo 4; s. 1237 - 1248
Hlavní autori:	Cadier, Benjamin, Bulsei, Julie, Nahon, Pierre, Seror, Olivier, Laurent, Alexis, Rosa, Isabelle, Layese, Richard, Costentin, Charlotte, Cagnot, Carole, Durand‐Zaleski, Isabelle, Chevreul, Karine
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Wolters Kluwer Health, Inc 01.04.2017
Predmet:	Aged Carcinoma, Hepatocellular - economics Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery Catheter Ablation - economics Catheter Ablation - methods Catheter Ablation - mortality Cohort Studies Cost analysis Cost-Benefit Analysis - methods Databases, Factual Disease-Free Survival Early Detection of Cancer - economics Early Detection of Cancer - methods Female France Hepatectomy - economics Hepatectomy - methods Hepatectomy - mortality Hepatology Humans Liver cancer Liver Neoplasms - economics Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - surgery Liver Transplantation - economics Liver Transplantation - methods Liver Transplantation - mortality Male Markov Chains Middle Aged Retrospective Studies Survival Analysis United States
ISSN:	0270-9139, 1527-3350, 1527-3350
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!